Elliott Mufson to Genetic Therapy
This is a "connection" page, showing publications Elliott Mufson has written about Genetic Therapy.
Connection Strength
0.141
-
Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains. Mov Disord. 2011 Jan; 26(1):27-36.
Score: 0.084
-
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005 May; 11(5):551-5.
Score: 0.057